Ameritox invests in depression blood test with Ridge licensing deal (Clinica)

From Clinica: Pain medication monitoring specialist Ameritox is branding out into depression after signing a deal that will allow it to sell Ridge Diagnostics’ blood test for major depressive disorder, MDDScore, to primary care and pain physicians. Ridge claims the product is the first clinically-available blood test for depression — albeit to a very limited market for now — and CEO Lonna Williams told Clinica the company hasn’t “seen anything else on the horizon.”

>Read the full story

Also, read the press release from Ridge Diagnostics, Inc. and Ameritox Ltd. Enter Into Licensing Agreement for Depression Biomarker Blood Test